Interactive journal club : experiences, perceptions, and narratives in Indian medical post-graduate education
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2022
Project Lead
Dr.Nachiket Shankar
Authors
Dr.Daron Mascarenhas, Dr.Nachiket Shankar
Project Status
completed
Project Type
Academic